Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
The Korean Journal of Internal Medicine|January 29, 2019
Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activityKichul Shin, Sung Soo Kim, Sang-Heon Lee, et al.
Journal of Korean Medical Science|November 9, 2016
Factors Contributing to Discordance between the 2011 ACR/EULAR Criteria and Physician Clinical Judgment for the Identification of Remission in Patients with Rheumatoid ArthritisYoon Kyoung Sung, Soo Kyung Cho, Dam Kim, et al.
Infection & Chemotherapy|July 4, 2020
The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic DiseaseYu Bin Seo, Su Jin Moon, Chan Hong Jeon, et al.
International Journal of Rheumatic Diseases|June 8, 2018
Factors associated with quality of life and functional disability among rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs for at least 6 monthsSang-Cheol Bae, Soo-Kyung Cho, Soyoung Won, et al.
Rheumatology International|January 30, 2017
Comparative effectiveness of treatment options after conventional DMARDs failure in rheumatoid arthritisYoon-Kyoung Sung, Soo-Kyung Cho, Dam Kim, et al.
The Journal of Rheumatology|September 3, 2015
Factors Associated with the Use of Complementary and Alternative Medicine for Korean Patients with Rheumatoid ArthritisMinkyung Han, Yoon-Kyoung Sung, Soo-Kyung Cho, et al.
The Korean Journal of Internal Medicine|September 14, 2016
Impact of early diagnosis on functional disability in rheumatoid arthritisDam Kim, Chan-Bum Choi, Jiyoung Lee, et al.
Annals of the Rheumatic Diseases|December 6, 2025
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatmentNancy Agmon-Levin, Stanislav Ignatenko, Alexander Gordienko, et al.
Plos Genetics|April 26, 2019
Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern AsiansJulio E Molineros, Loren L Looger, Kwangwoo Kim, et al.
Arthritis Research & Therapy|May 23, 2019
Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group studyMin-Chan Park, Hiroaki Matsuno, Jinseok Kim, et al.
Pageof 18